Detailed View
EWTX - Edgewise Therapeutics, Inc.
Latest filing: 2025-12-31 | Reporting: gaap
Market Cap
3,291,559,936
Adj EBIT (TTM)
-191,406,000
Enterprise Value
3,230,411,936
Last Price
30.61
Earnings Yield
-5.93%
Return on Capital
-36.42%
Capital
525,518,000
1Y Price Chart
Last Price: $30.61
1Y Change: 83.51%
As of 2026-05-01 | 1Y Change: 83.51%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -55,979,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -46,858,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -42,610,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -45,959,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -45,540,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -40,432,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -38,107,000 |
| 2024-03-31 | 10-Q | 2024 | 0 | -34,753,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.